In Canada, the non-formulary claims for GLP-1 RAs increased by more than fourfold from 14,088 claimants in 2016 to 60,120 claimants in 2021 [6]
The SELECT trial demonstrated a 20% reduction in major cardiovascular events (cardiovascular death, heart attack, stroke) in people with overweight or obesity and established cardiovascular disease
Handcrafted in Texas Vegan Pharmaceutical-Grade Peptides
Whether youre looking to combat fatigue, enhance skin clarity, recover from jet lag, or support your immune system, our bespoke IV therapy can deliver vital nutrients directly into your bloodstream for rapid results
Study 3 : In this study, Semaglutide demonstrated superior weight loss effects compared to other diabetes medications, further emphasizing its potential as a valuable tool in weight management
For ongoing support a maintenance schedule of one injection every four to twelve weeks is common, agreed at your free consultation